Moreover, a meta-analysis of The Cancer Genome Atlas (TCGA) melanoma data set revealed that increased FMR1 expression level significantly correlates with metastatic melanoma, risk of tumor relapse and reduced disease-free survival. This evidence concerns the gene FMR1 and neoplasm.